3,4-Diaminopyridine-induced noradrenaline release from CNS tissue as a model for action potential-evoked transmitter release: effects of phorbol ester
- 1 October 1989
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 169 (1) , 115-123
- https://doi.org/10.1016/0014-2999(89)90823-6
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Toxins in the characterization of potassium channelsTrends in Neurosciences, 1989
- The pharmacology of potassium channels and their therapeutic potentialTrends in Pharmacological Sciences, 1988
- Protein kinase C activation and α2‐autoreceptor‐modulated release of noradrenalineBritish Journal of Pharmacology, 1987
- Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12,13-dibutyrateNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986
- Enhancement of noradrenaline release by 12-O-tetradecanoyl phorbol-13-acetate, an activator of protein kinase CEuropean Journal of Pharmacology, 1986
- Inhibitory effect of taurine on 4-aminopyridine-stimulated release of labelled dopamine from striatal synaptosomesNeuropharmacology, 1986
- Potassium channels in isolated presynaptic nerve terminals from rat brain.The Journal of Physiology, 1985
- Voltage-dependent conductances of vertebrate neuronesTrends in Neurosciences, 1982
- Enhancement of synaptic transmission by 4‐aminopyridine in hippocampal slices of the rat.The Journal of Physiology, 1982
- Effects of 4-aminopyridine on the turnover of monoamines in the central nervous system of the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979